Our Scientific Networks
We have conducted some of the largest, most significant infectious diseases and vaccines (IDV) clinical trials on record. When you partner with us, you can be confident in getting the patient recruitment and retention numbers and high-quality data you need for your clinical trial.
Our Scientific Networks
In 2014, Julius Clinical founded ReSViNET, which has been an independent foundation since 2018. Our partnership with them allows us to provide our clients with exceptional operational support for RSV clinical trials and observational studies.
On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma” Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...
On May 10, our partner ReSViNET presented the webinar: Progress in RSV Vaccines and Monoclonal Antibodies In this webinar, Professor Barney Graham, MD, PhD, shared his views on the lanscape of RSV therapeutics. The webinar was hosted by Prof. D...
On April 26, we presented the webinar: RSV vaccine development for all ages, what lies ahead of us? In this webinar, Prof. Louis Bont, shared his views on the burden of RSV infections across generations and the latest advancements in monocl...
Explore our IDV capabilities, case studies, and other resources.
"*" indicates required fields
"*" indicates required fields